Retatrutide is a newly developed drug that acts as a strong GLP-1 receptor activator. This breakthrough approach holds significant promise for managing type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have demonstrate